v25i2

Dr Hugo Cogo-Moreira joined the School of Public Health as Assistant Professor in September 2020. His PhD thesis (2012, Universidade Federal de Sao Paulo, Department of Psychiatry) was named one of the three best Medical PhD theses in Brazil. It studied the effectiveness of music education on the language skills among impoverished children with reading difficulties living in the favelas of Sao Paulo. Components of his PhD and his training in applied biostatistics were conducted at the London School of Hygiene and Tropical Medicine, under supervision of Professor George Ploubidis. Dr Cogo-Moreira is interested in psychometrics and the design and analysis of randomised clinical trials under complex situations such as non-adherence, missing data, and multilevel structures. From 2018 to 2020, he was a senior research fellow of Alexander von Humboldt Foundation, working on advances in longitudinal data modelling at Free University of Berlin (Division of Methods and Evaluation). Dr Vijaykrishna Dhanasekaran joined the School of Public Health as Associate Professor in September 2020. Dr Dhanasekaran is an infectious disease scientist and has his BSc, MSc and MPhil from the University of Madras, India and PhD (2005) in Microbial ecology and evolution from The University of Hong Kong. In 2006, he joined HKUMed as a Postdoctoral Fellow in Virology, being promoted to Research Assistant Professor in 2009. In 2010, he joined Duke-NUS Graduate Medical School Singapore as Assistant Professor, before joining Monash University, Australia, as Associate Professor in 2016. There Dr Dhanasekaran established a computational biology group, building capacity in infectious disease research and computational biology within the Monash Biomedicine Discovery Institute. He also held an adjunct faculty position at the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in the Victorian Infectious Diseases Reference Laboratory (VIDRL). The overarching goal of his lab has been to apply computational and experimental methods at the intersection of medicine, epidemiology and population genetics to identify factors that shape the emergence and evolution of rapidly evolving pathogens. eyelid interventions, ocular surface problems, periorbital rejuvenation, thyroid eye disease and lacrimal apparatus related treatments. Dr Gilbert T Chua ( 蔡宇程 ) joined the Department of Paediatrics and Adolescent Medicine as Clinical Assistant Professor in July 2020. He graduated from the HKUMed MBBS programme in 2012 and joined the Department of Paediatrics and Adolescent Medicine in 2013, becoming a paediatric specialist in 2019. Dr Chua is also a subspecialty trainee in paediatric immunology, allergy and infectious diseases. He is a council member of the Hong Kong Paediatric Society and the Hong Kong Institute of Allergy, the regional junior working party representative of the Asia Pacific Society for Immunodeficiency, and a member of the Chinese Research Hospital Association Allergy Committee. Dr Chua’s areas of research interests include primary immunodeficiency, food and dust mite allergy and immunotherapy, and paediatric infectious diseases with a focus on paediatric COVID-19 infections. Dr Clive Chung Yik-sham ( 鍾亦琛 ) joined the School of Biomedical Sciences as Assistant Professor in May 2020. He received his first-class honours BSc degree in Chemistry in 2008 and his PhD at HKU in 2013. Subsequently, he completed his postdoctoral training at HKU on inorganic medicines and drug delivery. In 2016, he received Croucher Postdoctoral Fellowship and moved to UC Berkeley, working on molecular imaging to unravel roles of reactive oxygen species (ROS) and copper in biology. In 2018, he joined Professor Daniel K Nomura at the Novartis-Berkeley Center for Proteomics and Chemistry Technologies, discovering new activity- based compounds that modulate autophagy and mTORC1 signalling. Dr Chung applies an integrated biochemical approach to his research. His lab is developing novel chemoproteomic platforms and functional tools for investigating reversible cellular modifications (e.g. redox signalling). Additionally, the lab uses activity-based protein profiling (ABPP) to create new drug lead compounds, optimise lead structures, and translate the research into clinical applications. 47 Medical Faculty News